Legend Biotech (LEGN) Long-Term Debt Issuances (2020)
Legend Biotech's (LEGN) quarterly Long-Term Debt Issuances came in at -$4000.0 in Q4 2020.
Powered by 
Analysis
Legend Biotech (LEGN) Long-Term Debt Issuances (2020) Analysis & Trends
Legend Biotech (LEGN) has reported Long-Term Debt Issuances for 1 consecutive years, with -$4000.0 the latest figure, recorded in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | Taysha Gene Therapies | 1.82 Bn | 1.82 Bn | - | - |